Register for updates

 
 

Medicine & Health
RSS Feed
Food Supplement May Be Key to Treatment of Rare Disease
Wednesday, December 21, 2016 9:00:00 AM

Familial Dysautonomia may be slowed by phosphatidylserine, TAU researchers say

A new Tel Aviv University study finds that a popular food supplement called phosphatidylserine may be instrumental in reversing the detrimental effects of Familial Dysautonomia (FD), a debilitating neurodegenerative disorder that affects approximately 1 in 31 Jewish people of Eastern European, or Ashkenazi, ancestry. FD affects aspects of the autonomic nervous system such as swallowing, sweating, and pain sensitivity, and places patients at increased risk for pulmonary and gastrointestinal complications.

The research, led jointly by Prof. Gil Ast and Prof. Eran Perlson of TAU's Sackler School of Medicine, generated a mouse model of FD to examine the neuron degeneration caused by FD and to observe the positive effects of the novel therapy. The study was published in PLOS Genetics.

Trucks, highways, and neurons

"Neurons are the longest cells in our body," said Prof. Ast. "'Highways' along our neurons allow 'trucks' with 'cargo' to supply our neurons with essential supplies. In most neurodegenerative diseases these highways — called microtubules — and the axonal transport process are impaired. Our study demonstrates that alterations in the stability of microtubules and disruptions in the transport may lead to FD."

The research team, including Shiran Naftelberg-Blonder and other TAU students, generated a mouse model of FD. The mice exhibited symptoms similar to those experienced by human patients with FD, including developmental delays, sensory abnormalities, unstable microtubules, and impairment of axonal retrograde transport of nerve growth factor.

"We found that in neurons from our FD mice, the microtubular highways were impaired by elevated levels of an enzyme called HDAC6," said Prof. Ast. "This impairment removed the adhesive that connects the 'bricks' of the highway. This led to less stabilized highways and to the slower movement of cargo along it."

Once the mouse exhibiting FD symptoms was generated, the researchers administered a phosphatidylserine treatment, which lowered the level of the enzyme that removed the "glue" from the "bricks" of the microtubular highways. Phosphatidylserine contains both amino acids and fatty acids and is known to be effective in slowing down long-term memory loss.

Finding a "path" to treatment

The researchers found that the treatment with phosphatidylserine enhanced the stability of the microtubular "highways" and improved the movement of "cargo" along these pathways. "We identified the molecular pathway that leads to neurodegeneration in FD and demonstrated that phosphatidylserine has the potential to slow progression of neurodegeneration," said Prof. Ast.

"Phosphatidylserine can repair the activity in neurons from the FD mouse by reducing the amount of the enzyme that removes the 'glue' from the 'bricks,'" Prof. Ast continued. "This elevates the stability of the 'highways' and increases essential cargo movement along these neurological pathways."

The researchers are currently researching ways of improving the delivery of phosphatidylserine to the nervous system. Teva Pharmaceuticals contributed support for this research through the National Network of Excellence.




Latest News

TAU Study Links Cannabis Use in Adolescence to Schizophrenia

Psychoactive compound in cannabis may trigger the brain disorder, researchers say.

Violent Attacks Against Jews Declined 12% in 2016, But Anti-Semitic Hate Speech Spiked

U.S. college campuses saw a 45% rise in anti-Semitism of all forms, annual TAU Kantor Center study reports.

Israeli Student Film Sets Guinness World Record

Lior Geller's Roads noted for most awards won by a short student film.

Tiny Whiteflies Provide Insight into Stabilizing Manmade Drones during Takeoff

The insects spread their wings only after leaping, rotating and reversing direction in midair, TAU researchers say.

Where the Jordan Stops Flowing

Regional cooperation key to river restoration strategy that could be emulated around the world, says TAU researcher.

Infant Vitamin B1 Deficiency Leads to Poor Motor Function and Balance

Lack of vitamin has long-term consequences for children's health, TAU researchers say.

Scientists Discover Mechanism That Causes Cancer Cells to Self-destruct

Modifying specific proteins during cancer cell division unleashes a natural killing mechanism, say TAU researchers.

Insulin Resistance May Lead to Faster Cognitive Decline

Executive function and memory are particularly vulnerable to the effects of insulin resistance, TAU researchers say.

Study Finds Disruptive Children Do Not Inspire Similar Behavior in Their Siblings

Siblings are more likely to learn how not to behave, say TAU researchers.

Sponge Bacterium Found to Encapsulate Arsenic Drawn from Environment

Entotheonella sequesters and neutralizes toxins within sponge host, say TAU researchers.

Outdoor Adventure Program Is a Promising Complementary Treatment for Autism Spectrum Disorder

Challenge-based intervention may be effective in reducing the severity of autism symptoms, TAU researchers say.

Ancient Jars Found in Judea Reveal Earth's Magnetic Field is Fluctuating, Not Diminishing

New evidence says geomagnetic force "spiked" in 8th century BCE, say TAU, Hebrew University, UC San Diego researchers.

The Zuckerman Post-Doctoral Scholarship Program at TAU Calls for Applications

Initiative designed to support future generations of leaders in STEM disciplines in the US and Israel.

Drug Candidate Stabilizes Essential Transport Mechanism in Nerve Cells

NAP blocks formation of "tangles" that contribute to Alzheimer's disease, says TAU researcher.

contentSecondary
c

© 2017 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University